|Bid||0.00 x 2900|
|Ask||0.00 x 800|
|Day's Range||39.54 - 40.20|
|52 Week Range||30.56 - 45.00|
|Beta (3Y Monthly)||1.03|
|PE Ratio (TTM)||7.16|
|Earnings Date||Apr 30, 2019|
|Forward Dividend & Yield||1.52 (3.85%)|
|1y Target Est||47.14|
The mid-engine Chevy Corvette is coming soon, but if you're looking for a good deal on a C7 'Vette, now might be the time to visit your local dealer, or really any Chevrolet dealer nationwide. There are about 9,000 unsold Corvettes sitting on various dealer lots, and the production facility in Bowling Green, Ky., continues to churn out more and more of them. There are four main models — Stingray, Grand Sport, Z06 and ZR1 — with three engines, two transmissions and a number of optional performance packages.
General Motors Co Chief Executive Mary Barra will not come before Canadian legislators to answer questions about the automaker's future in the country, but lower-ranking executives will appear, a lawmaker said on Thursday. GM said in November it would close its Oshawa, Ontario, assembly plant by year-end, part of a broad restructuring affecting four other plants in the United States, as it cuts costs and invests in electric and self-driving vehicles.
Robert Bruce (Trades, Portfolio)'s Bruce & Co. sold shares of the following stocks during the fourth quarter. The firm trimmed 25.88% off its General Motors Co. (GM) position. Warning! GuruFocus has detected 4 Warning Signs with SPN.
Consumer Reports on Thursday pulled a recommendation for Tesla Inc's Model 3, citing reliability problems, and the influential U.S. magazine turned up the pressure on other automakers to include crash-avoiding automatic braking as standard equipment. The magazine's decision to withdraw its endorsement for the Tesla Model 3 less than nine months after recommending the electric sedan highlighted questions about quality that Tesla has faced since the vehicle's difficult launch. Tesla shares fell 3.4 percent to $292.19 in afternoon trading Thursday on the Nasdaq.
The tide is turning. Goldman Sachs is now calling an end to an investing strategy it first recommended two years ago."For the past two years we have consistently advocated buying strong balance sheet stocks, but we believe the risk-reward has shifted in favor of closing this recommendation," Goldman Sachs' equity strategist David Kostin wrote on Feb. 8. "We no longer recommend strong balance sheets."These "strong balance sheet" stocks include major names like Facebook (NASDAQ:FB), Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) and Costco (NASDAQ:COST). So far this strategy has done very well for investors. Goldman Sachs' basket of 50 strong balance sheet stocks outperformed weak balance sheet stocks by 25 percentage points since early 2017.InvestorPlace - Stock Market News, Stock Advice & Trading TipsHowever the Federal Reserve's recent dovish commentary indicates that the hiking cycle may have come to an end. This should ease pressure on corporate balance sheets -- leading Kostin to say: "Our recent research showed that strong balance sheets are among the worst performing factors during the 12 months following the end of Fed hiking cycles, when U.S. Treasury yields typically also decline." * 7 Healthy Dividend Stocks to Buy for Extra Stability Plus the firm's optimistic outlook for the economy is also a boost to weaker balance sheet stocks. Investors tend to rotate to strong balance sheet stocks in times of weak or decelerating economic growth. So which stocks should you be looking at now? Here are six stocks from the firm's weak balance sheet basket. I also use TipRanks' data to see what the analysts are saying about these picks.Let's take a closer look now: Stocks To Buy: Delta Airlines (DAL)Despite the government shutdown costing Delta Air Lines (NYSE:DAL) $25 million in revenue for January, this stock still gets the thumbs up from the Street.The airline carrier recently reported fourth-quarter earnings that beat expectations thanks to strong travel demand. Delta's total revenue rose to $10.74 billion during Q4, up 5% year-over-year."2018 was a successful year for Delta with record operational reliability, increasing customer satisfaction, and solid financial results in the face of higher fuel costs" said CEO Ed Bastian. "As we move into 2019, we expect to drive double-digit earnings growth through higher revenues, maintaining a cost trajectory below inflation, and the modest benefit from lower fuel costs."As Tigress Financial's Ivan Feinseth (Track Record & Ratings) notes, a strong economy, low unemployment and increases in consumer spending are driving record levels of airline travel.That's reflected in the company's strong buy consensus and 21% upside potential.Want to learn more about Delta? Get the free DAL Stock Research Report. AT&T (T)AT&T (NYSE:T) is a leading provider of IP, broadband, video and wireless services. And through its recent Time Warner acquisition it is now a top-four producer of content globally.2019 is about positioning for better services growth in 2020 and beyond, says Oppenheimer's Timothy Horan (Track Record & Ratings). Horan, like most of the Street, currently has a buy rating on T stock. His bullish call comes with a $41 price target for 38% upside potential.T stock has the ability to integrate its services in unique ways and hassubstantial room to use virtualized technologies to greatly reduce operating and capital expenditures. "We believe that combined with TWX, FCF/share could grow 6% per year" writes the analyst. * 10 Smart Money Stocks to Buy Now Overall, T has a strong buy consensus with 11 buy ratings vs just three hold ratings. Get the T Stock Research Report. Mylan (MYL)If you haven't heard of Mylan NV (NASDAQ:MYL) before, listen up. This is a global healthcare company making high quality medicines available to everyone who needs them. In fact, Mylan is the U.S.'s second largest provider of prescription medicine with over 650 different products, including the EpiPen.One product in particular is generating attention right now. That's asthma drug Advair. "Long awaited generic Advair approval comes and at a key time" cheered RBC Capital's Randall Stanicky (Track Record & Ratings) recently. While overdue, MYL received FDA approval for its generic Advair (Wixela Inhub) on Jan. 30. Shares jumped 7% on the news.Stanicky has a buy rating on the stock with a $50 price target, suggesting 56% upside lies ahead. "MYL remains one of the 'cheapest' generic stocks" enthuses the analyst. That's because its high-value pipeline comes with push-back over (i) low P&L visibility and (ii) governance concerns.That said, valuation is very compelling with multiple catalysts that could surprise to the upside. Bottom line: "Stronger remaining core base combined with emerging complex generic pipeline should position shares for an upward move."However not all analysts are so positive. The Street is currently divided between buy and hold ratings. Get the MYL Stock Research Report. CBS Corp (CBS)Even though mass media stock CBS Corporation (NYSE:CBS) just reported a Q4 earnings miss, analysts are staying firmly on side. From top analysts the consensus remains a strong buy. Plus, CBS shares are up 15% since the beginning of this year.Top Barrington Research analyst James Goss (Track Record & Ratings) has reiterated his CBS buy rating with a $72 price target. That indicates compelling upside potential of 41%. "We view CBS as one of our best value media ideas" Goss writes.While the lack of syndication deals was largely known going into the quarter, Goss believes consensus had failed to adjust estimates for this high-margin revenue stream. The result: a roughly $100 million revenue and 3-cent EPS miss.But even so, CBS has just announced that it has hit its 8 million OTT subscriber goal. Prepare yourselves, because this is about two years ahead of schedule. * 7 Financial Stocks With Accelerating Growth "At this point, even with the uncertainty at the top and the potential for M&A, CBS trades at a paltry 7x 2019E OIBDA, at a discount to our broadcast affiliate peer group despite owning better stations and all of the content, plus a thriving OTT business" concludes the analyst. Get the CBS Stock Research Report. General Motors (GM)"Motoring into 2019" cheers RBC Capital's Joseph Spak (Track Record & Ratings). He made the comment following the General Motors Company's (NYSE:GM) solid 4Q18 earnings results.The details of the quarter -- which were strong -- should lead investors to have more confidence in 2019 EPS says Goss. For example, management guided the tax rate to 16%-18% versus the expected 20%.Plus the analyst continues to view GM's transformation as underappreciated. "Recent restructuring actions that should lead to ~$4.5bn savings run-rate in 2020 significantly improves GM's positioning" he writes.And it seems like the Street agrees. If we zero in on top-performing analysts, we can see GM holds only buy ratings right now. Get the GM Stock Research Report. Allergen (AGN)Botox maker Allergan (NYSE:AGN) is one the highest-quality companies in the Pharma industry. It is also one of the most-innovative. Allergan is currently advancing a number of key pipeline products through late stage clinical trials, including new oral drugs for migraine, rapastinel for major depressive disorder and CVC for NASH.However shares have underperformed, with prices sinking 15% in the last year. That's down to a disappointing revenue outlook for 2019 and increasing competition for drugs including botox.Plus billionaire hedge fund manager David Tepper is now suggesting the company should sell itself. His Appaloosa hedge fund owns 1.5 million shares in AGN -- down 842,591 shares from Q3. So far Allergan has refused Tepper's suggestion to split the chairman and CEO roles, currently held by Brent Saunders.However, analysts still see a buying opportunity at hand. Mizuho Securities' Irina Rivkind Koffler (Track Record & Ratings) is a top-rated analyst according to TipRanks. She has a buy rating on the stock with a $200 price target. That indicates 45% upside potential from current levels. Koffler cites the company's 4Q18 top and bottom-line beat, down to better Restasis durability, share buybacks and strong injectables. * Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks? "We valued AGN solely via DCF analysis of 2018-2025 cash flows. We utilize a weighted average cost of capital of 11% and a 3% terminal growth rate. This analysis generates a valuation of $213 per share, and supports our Buy rating" explains the analyst. Get the AGN Stock Research Report.TipRanks.com offers exclusive insights for investors by focusing on the moves of experts: Analysts, Insiders, Bloggers, Hedge Fund Managers and more. See what the experts are saying about your stocks now at TipRanks.com. As of this writing, Harriet Lefton did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Smart Money Stocks to Buy Now * The 10 Best Cheap Stocks to Buy Right Now * 7 Restaurant Stocks to Watch in 2019 Compare Brokers The post 6 Hot Stocks For Goldman Sachs' New Investing Strategy appeared first on InvestorPlace.
The 2020 GMC Acadia is getting a host of styling, technology, and power upgrades for the 2020 model year as part of a midcycle refresh.
Ford Motor Co's oldest factory in Brazil, slated for closure later this year, was a giant among auto plants, occupying a sprawling 12 million square feet (111.5 hectares), bigger than many of the automaker's U.S. facilities. Ford announced on Tuesday it will close the factory and exit its heavy commercial truck business in South America as part of a global restructuring. Overall, Ford's Sao Bernardo plant produced 33,000 cars and heavy trucks in 2018, or just 11 vehicles per employee.
Jerry Dias, the leader of Canada's auto union, is unsparing in his rhetorical attacks on General Motors Co's decision to close its Oshawa, Ontario, assembly plant and lay off thousands of union workers by year-end. Dias promised "drastic measures" to compel GM to extend production of sedans and pickups, including the Silverado, to Sept. 21, 2020, when the current labor contract expires. For more than a century, GM's complex in Oshawa, a city east of Toronto, has been an economic engine for Ontario and Canada, anchored by thousands of highly paid manufacturing jobs.
The fourth quarter stock plunge was the perfect buying opportunity for value investors. Did Berkshire Hathaway's portfolio jump in to buy?
The all-electric 2019 Chevrolet Bolt lives on. It was the hybrid Chevy Volt that General Motors killed.
On April 7, 2017, Tesla (NASDAQ:TSLA) stock cleared $300 for the first time. Tesla stock would close that day at $302.54. Yesterday, TSLA stock closed at $302.56.Source: Shutterstock So over the last 22+ months, TSLA stock has risen… 0.07%. Given the intensity of the debate over TSLA -- without a doubt the biggest battleground stock in the market -- the lack of movement is beyond ironic. Where does Tesla stock go from here? There are cases on both sides. I've long leaned toward the bearish case: I argued in December that TSLA would decline in 2019. That prediction has been right so far, with the stock down 9%. But Tesla has managed to confound the doubters so far, and there are still reasons to believe it will do so again. The Case for Tesla StockAt this point, the bull case for TSLA has both short-term and long-term aspects. The long-term case is the same as it's been for years now: Tesla has the opportunity to revolutionize worldwide energy usage. The company isn't just about the Model 3 -- or even just about automobiles. The solar division, Powerwall, and other future initiatives all offer additional profit opportunities.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * The 10 Best Cheap Stocks to Buy Right Now A $52 billion market capitalization hardly suggests Tesla stock is cheap, but it's puny compared to what the valuation could be if Tesla achieves even some of its goals across the energy space. ARK Invest famously has put a $4,000 per share bull case price target on TSLA stock -- which would suggest a valuation over $500 billion. Given that Exxon Mobil (NYSE:XOM) is worth about $375 billion, including debt, that figure perhaps isn't as ludicrous as it sounds.In the short term, meanwhile, Tesla stock is getting to a point where it doesn't look that expensive. 2020 analyst EPS estimates are over $9 per share, suggesting a 33x forward P/E multiple. That's a big number as far as auto stocks go -- General Motors (NYSE:GM) and Ford Motor Company (NYSE:F) both trade in the single digits -- but it's a valuation that Tesla at least can grow into. As the company expands into Europe and China, its earnings should grow, and that multiple should come down. The Case Against TSLA StockThe case against Tesla stock is starting to build, however, and it comes down to one simple problem: trust. For all the arguments over convertible debt maturities and 25% gross margins and weekly production levels, the broad argument is rather simple.If Tesla can build cars more effectively and more efficiently than existing manufacturers, TSLA stock probably rises. It will make more money per car than anyone else -- and enough to fund its moves into semi trucks, energy storage, and other areas.If it doesn't, TSLA stock falls. Auto companies aren't valued at 30x earnings -- or even 20x. Earnings expectations come down, multiples compress, and the Tesla stock price comes down significantly. And so far, we're simply not seeing much evidence that Tesla is that much better than anyone else at production.Tesla hasn't released a $35K Model 3 yet, as promised. It built vehicles in a tent. Target after target has been missed. For all the hype about the 5,000 per week production target (sort of) reached in late June, Tesla hasn't been able to get back to that level on a consistent basis.There's a lot of big talk and big promises out of Tesla. The results -- thin profitability and missed goals -- haven't been good enough yet. The Trust ProblemAnd with each passing month, it becomes harder to trust Tesla and CEO Elon Musk. Musk clearly violated his settlement with the SEC with Tweets this week initially guiding for production of 500,000 cars this week.The CEO did correct the tweet four hours later, admittedly. But for those bulls chalking the Tweet up to a simple mistake, it's worth noting that Musk did the exact same thing on the Q4 conference call last month. He projected 350,000 to 500,000 Model 3s in 2019 -- after the shareholder letter issued the same day only guided for 360,000 to 400,000.At this point, investors perhaps don't care. Soon after the tweet, Tesla's general counsel resigned after two months on the job, the latest in a series of executive departures. TSLA stock dropped just 1%.Investors should care, however. Given the goals here, execution needs to be close to perfect at worst. It hasn't been. A CEO who continually overpromises doesn't help on that front. Nor does the revolving door of executives. * 7 Healthy Dividend Stocks to Buy for Extra Stability The biggest reason to see upside in Tesla stock is the big promises -- and the big hopes. The biggest risk to TSLA stock is that the company won't deliver. For 22 months, the market hasn't made up its mind as to which is more likely. At some point, it will. Right now, it still seems far too difficult to trust this company -- and this CEO -- to deliver the rewards they promise.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Smart Money Stocks to Buy Now * The 10 Best Cheap Stocks to Buy Right Now * 7 Restaurant Stocks to Watch in 2019 Compare Brokers The post The Risks and Rewards of Tesla Stock appeared first on InvestorPlace.
Has Trump Managed to Breach the Great Wall of China?(Continued from Prior Part)Seven pointsAs noted in the previous article, US-China trade talks seem to be making progress, which is evident in China’s (EEM) (FXI) recent statements. The country